10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
Cogent Inc. (COGT)
Market is closed
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Highbridge Capital Management Glenn Russell Dubin | 0 | $0 | -100% | 0% |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.50 | 5,000 | Director | 4,000 | 2010-10-08 | Filing | |
| $10.50 | 1,860,436 | Officer, Director | 0 | 2010-10-08 | Filing | |
| $10.50 | 1,860,436 | Officer, Director | 0 | 2010-10-08 | Filing | |
| $10.50 | 5,250,000 | Officer, Director | 0 | 2010-10-08 | Filing | |
| $10.50 | 10,139,128 | Officer, Director | 0 | 2010-10-08 | Filing |
News See All
10 Best Biotech Stocks To Buy Under $20
The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological advancements, and government support.
10 Best Small-Cap Healthcare Stocks To Buy Now
In difficult economic times, healthcare equities are sometimes regarded as a defensive investment.
5 Best Biotech Stocks To Buy Under $20
In this article, we are going to take a closer look at five best biotech stocks to buy under $20.
5 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 5 best medical stocks to buy under $10.
5 Best Booming Stocks to Buy Right Now
Seattle, Washington-based Alpine Immune Sciences Inc (NASDAQ:ALPN) ranks fifth in our list of the best booming stocks to buy right now.
5 Small-Cap Stocks with High Potential
In this article, we will take a look at the 5 small-cap stocks with high potential.
Hedge Fund and Insider Trading News: Gabe Plotkin, Odey Asset Management, Citadel LLC, Gullane Capital Partners, Three Arrows Capital, NextEra Energy Inc (NEE), GameStop Corp. (GME), and More
Trip Miller, founder of the Nashville, Tennessee hedge fund Gullane Capital Partners, is trying to put together a group of investors to buy the Tampa Bay Rays for $1.85 billion, multiple sources have ...
5 Cash-Rich Small Cap Stocks To Invest In
Needham analyst Ami Fadia initiated coverage of Cogent Biosciences with a Buy rating and $24 price target on December 14.
14 Small-Cap Stocks with High Potential
Small-cap investors took a beating in 2022 as data shows that small-cap stocks are near their all-time lows.
Billionaire Hedge Funds
